Abstract:Non-typhoidal Salmonella enterica strains, including serovar Typhimurium (STm), are an emerging cause of invasive disease among children and the immunocompromised, especially in regions of sub-Saharan Africa. STm invades the intestinal mucosa through Peyer's patch tissues before disseminating systemically. While vaccine development efforts are ongoing, the emergence of multidrug resistant strains of STm affirms the need to seek alternative strategies to protect high-risk individuals from infection. In this report, we investigated the potential of an orally administered O5 serotype-specific IgA monoclonal antibody (mAb), called Sal4, to prevent infection of invasive Salmonella enterica serovar Typhimurium (STm) in mice. Sal4 IgA was delivered to mice prior to or concurrently with STm challenge. Infectivity was measured as bacterial burden in Peyer's patch tissues one day after challenge. Using this model, we defined the minimal amount of Sal4 IgA required to significantly reduce STm uptake into Peyer's patches. The relative efficacy of Sal4 in dimeric and secretory IgA (SIgA) forms was compared. To assess the role of isotype in oral passive immunization, we engineered a recombinant IgG1 mAb carrying the Sal4 variable regions and evaluated its ability to block invasion of STm into epithelial cells in vitro and Peyer's patch tissues. Our results demonstrate the potential of orally administered monoclonal IgA and SIgA, but not IgG, to passively immunize against invasive Salmonella. Nonetheless, the prophylactic window of IgA/SIgA in the mouse was on the order of minutes, underscoring the need to develop formulations to protect mAbs in the gastric environment and to permit sustained release in the small intestine.The bacterium Salmonella enterica is responsible for significant morbidity and mortality in the developed and developing worlds. While the pathogen is most renowned as the causative agent of typhoid fever, the emergence of invasive non-typhoid strains like S. enterica serovar Typhimurium (STm) are of great concern because of their propensity to cause severe disease in children under the age of five. In this report, we demonstrate in a mouse model that oral administration of a monoclonal antibody targeting the surface of STm is able to prevent the bacterium from infecting gastrointestinal tissues, the first step in the dissemination process. We show that IgA antibodies (which are normally found in the gut) were far superior than an equivalent IgG antibody (normally found in blood) at defending the intestine from STm infection. These results lay the foundation for future studies aimed at the development of an orally administered antibody cocktail capable of providing temporary immunity to pathogens like S. enterica.

Preparation and Evaluation of Monoclonal Antibodies Against Six Salmonella Pathogens

Preparation and Characterization of Murine Monoclonal Antibodies Against ESAT-6 Antigen of Mycobacterium tuberculosis

Preparation and Characterization of Monoclonal Antibodies Against Pathogenic Stenotrophomonas Maltophilia in Fish

Multiple immunodominant O-epitopes co-expression in live attenuated Salmonella serovars induce cross-protective immune responses against S. Paratyphi A, S. Typhimurium and S. Enteritidis.

Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.

Prokaryotic Expression of Salmonella Paratyphi A Nmpc Gene and Immunoprotective Effect of the Expressed Product

Serum Bactericidal Assay: New Role In Salmonella Detection

Preparation and Identification of Monoclonal Antibodies against Mycoplasma bovis

Immunogenicity and cross-protective efficacy induced by delayed attenuated Salmonella with regulated length of lipopolysaccharide in mice

Screening of the Salmonella paratyphi A CMCC 50973 strain outer membrane proteins for the identification of potential vaccine targets.

Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice

Attenuated Salmonella Typhimurium Expressing Salmonella Paratyphoid A O-antigen Induces Protective Immune Responses Against Two Salmonella Strains

Preclinical evaluation of OMVs as potential vaccine candidates against Salmonella enterica serovar Enteritidis infection

Preparation and Identification of Monoclonal Antibodies against Bordetella bronchiseptica from Rabbits

Immunogenicity And Cross-Protective Efficacy Induced By Outer Membrane Proteins From Salmonella Typhimurium Mutants With Truncated Lps In Mice

Preparation of divalent camelid single-domain antibody and its application in immunoassays for Salmonella detection in food

Preparation and Applications of Monoclonal Antibody Against the Pathogenic Vibrio Parahaemolyticus from Pseudosciaena Crocea

Preparation and preliminary characterization of monoclonalantibodies against Pheromonicin-and-Staphylococcus aureus

Differential Immune Responses of C57BL/6 Mice to Infection by Salmonella Enterica Serovar Typhimurium Strain SL1344, CVCC541 and CMCC50115

Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies

Establishment and Application of Hybridoma Cell Lines Secreting Monoclonal Antibodies Against Enterotoxigenic Escherichia Coli Heat-Stable Enterotoxin Ⅰ